Clinical • P1 data • Clinical Trial,Phase I • Journal
|
CD8 (cluster of differentiation 8) • IFNG (Interferon, gamma) • TNFA (Tumor Necrosis Factor-Alpha) • CXCL10 (Chemokine (C-X-C motif) ligand 10) • CD163 (CD163 Molecule) • IL18 (Interleukin 18)
|
spartalizumab (PDR001) • NIZ985